Physician Search

Consuelo Wilkins, MD, MSCI, Senior Vice President for Health Equity and Inclusive Excellence for Vanderbilt University Medical Center (VUMC) and Senior Associate Dean for Health Equity and Inclusive Excellence for Vanderbilt University School of Medicine, always knew she wanted to be a physician. "Health equity was built into everything I did, even if I didn’t know it or recognize it at the time," Wilkins said. "I have always learned and believed that people are the same — everyone deserves to be healthy, and everyone should have the best opportunities to take care of themselves and their families." Click below to learn more about health equity initiatives.

https://momentum.vicc.org/2021/09/everyone-deserves-to-be-healthy/

Vanderbilt was the lead site for an NIH-funded, phase 2, multicenter influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant (HCT) recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. Natasha Halasa, MD, MPH and colleagues recently published in the New England Journal of Medicine, that two doses of high-dose trivalent flu vaccine resulted in higher amounts of influenza-specific antibodies than two doses of standard dose quadrivalent vaccine.

https://news.vumc.org/2023/03/02/high-dose-flu-vaccine-beneficial-for-pediatric-stem-cell-transplant-patients/

Filter By:
Search by Keyword:

Displaying 171 - 180 of 300

FULCRUM VT- Cryoablation for Monomorphic Ventricular Tachycardia IDE Early Feasibility Study

Disease Sites: Not Available

Phase:

Investigator: Stevenson, William

NCTID:

Protocol No: CRE-ARR0019

CY 6022 - A FOLLOW-UP, OPEN-LABEL, RESEARCH EVALUATION OF SUSTAINED TREATMENT WITH AFICAMTEN (CK-3773274) IN HYPERTROPHIC CARDIOMYOPATHY (HCM)

Disease Sites: Not Available

Phase:

Investigator: Brinkley, Douglas

NCTID:

Protocol No: CRE-CHF0014

ACCESS-MANTA Registry - Prospective Clinical Registry evaluating contemporary MANTA outcomes (ACCESS-MANTA Registry)

Disease Sites: Not Available

Phase:

Investigator: Goel, Kashish

NCTID:

Protocol No: CRE-INT0012

SENSATION: TREATMENT OF SYMPTOMATIC DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION WITH THE SYNAPTIC COMPLIANT CRYOABLATION BALLOON AND SYSTEM

Disease Sites: Not Available

Phase:

Investigator: Richardson, Travis

NCTID:

Protocol No: CRE-ARR0022

Equity in Modifying Plaque Of WomEn with UndeRtreated Calcified Coronary Artery Disease (EMPOWER CAD)

Disease Sites: Not Available

Phase:

Investigator: Sutton, Nadia

NCTID:

Protocol No: CRE-CHF0017

A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects with Hypertension

Disease Sites: Not Available

Phase: III

Investigator: Not Available

NCTID: NCT02910414

Protocol No: CRE-INT0003

TAVR Low Risk & CAS - Transcatheter Aortic Valve Replacement (TAVR) in Patients with the Medtronic Transcatheter Aortic Valve Replacement System (TAVR) in Patients at Low Risk for Surgical Aortic Valve Replacement (SAVR) Continued Access Trial

Disease Sites: Not Available

Phase: IV

Investigator: Goel, Kashish

NCTID: NCT02701283

Protocol No: CRE-INT0008

Aday, Aaron/Novartis Pharmaceuticals Corporation/ (CADPT15A12201)

Disease Sites: Not Available

Phase:

Investigator: Aday, Aaron

NCTID: NCT06097663

Protocol No: VTRACC006

Occluflex - Prospective randomized multi-center controlled clinical investigation comparing PFO outcomes of the Occlutech Figulla Flex II PFO Occluder to standard of care PFO occlusion.

Disease Sites: Not Available

Phase: II/III

Investigator: Piana, Robert

NCTID: NCT05069558

Protocol No: CRE-INT0005

Genetics of Appendix Cancer: The GAP Study

Colon

Disease Sites: Colon

Phase: N/A

Investigator: Holowatyj, Andreana

NCTID: NCT05734430

Protocol No: VICCGI2280